Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

SRTA

HOLD

Strata Critical Medical, Inc. · Healthcare · United States · $436M · Avg Vol: $6M/d

45
StockRank
Get insider-trade alerts
Q
44
V
36
M
59
P/E (TTM)
—
ROE
-6.4%
D/E
0.0x
Dividend %
—
Dir. Trades · 180d
−$802.6K →
Buybacks · 180d
None →

COMPANY DESCRIPTION

Strata Critical Medical, Inc. develops and commercializes advanced medical technologies designed for critical care and emergency medicine. The company focuses on innovative solutions that improve patient monitoring, diagnostics, and intervention in high-acuity settings. Its specialized product portfolio aims to address critical gaps in emergency medical treatment, positioning it in a niche market with significant potential for impact on patient outcomes.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue146.1M225.2M146.8M197.1M10.5%228.6M274.2M303.6M24.1%
EPS-0.38-0.76-0.340.48—-0.19-0.14-0.01—
Shares71.7M75.1M79.4M86.7M+21.0%86.5M———
Debt18.3M24.5M3.0M3.3M-43.5%4.5M———
Equity274.5M234.3M221.9M279.1M0.6%————
Op CF-37.1M-32.3M-2.5M-48.9M—-44.8M———
Inv CF79.3M17.1M-1.0M69.8M—————
Fin CF-1.1M-76.0K-5.8M-8.9M—————
Loading 1Y...
PRICE (1Y)-5.3%
5.015.235.455.675.89Jun 12Jul 7Jul 27
SMA 50SMA 200
Close
$5.14
RSI (14)
46.3
52W High
$6.50
From 52W High
0.8%

SCORE BREAKDOWN

Quality
44
ROIC
-7.3%38.1
ROE
-6.4%39.7
GP/Assets
14.8%36.3
Op. Margin
-2.8%33.7
FCF/Assets
-7.4%32.2
Piotroski
550.0
Int. Cover
—N/A
D/E Ratio
0.02x81.3
Current Ratio
5.93x75.7
Value
36
P/E (TTM)
—N/A
EV/EBITDA
-3486.4x25.0
P/FCF
—N/A
P/B
1.5x71.0
P/S
1.9x69.2
Div Yield
—N/A
Momentum
59
52W High %
79%69.0
RS 6M
-14%54.7
SMA 50/200
1.11x83.4
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$436M
P/E (Forward)
—
Gross Margin
21.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of SRTA are excluded.

TickerCompanyMkt CapStockRankSignal
SRTAStrata Critical Medical, Inc.(you)$436M45HOLD
TOIThe Oncology Institute, Inc.$498M45HOLD
AIRSAirSculpt Technologies, Inc.$325M51HOLD
SNDASonida Senior Living, Inc.$2.0B43HOLD
USPHU.S. Physical Therapy, Inc.$1.1B59HOLD
PARKPark Dental Partners, Inc.$85M44HOLD
CYHCommunity Health Systems, Inc.$385M78BUY
GMRSGMR Solutions Inc.$701M71BUY
WWWW International, Inc.$133M57HOLD
AGLagilon health, inc.$1.6B35HOLD

Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.6%

Strata Critical Medical, Inc. (SRTA) — Stock Score Summary

Strata Critical Medical, Inc. (SRTA) has a MoatMap StockRank of 45/100 based on Quality (44/100), Value (36/100), and Momentum (59/100) factor scores. The current signal is HOLD.

Strata Critical Medical, Inc. develops and commercializes advanced medical technologies designed for critical care and emergency medicine. The company focuses on innovative solutions that improve patient monitoring, diagnostics, and intervention in high-acuity settings. Its specialized product portfolio aims to address critical gaps in emergency medical treatment, positioning it in a niche market with significant potential for impact on patient outcomes.

Key Financial Metrics

Price$5.14
Market Cap$436M
Price/Book1.53
Return on Equity-6.4%
Return on Invested Capital-7.3%
Debt/Equity0.02x
Gross Margin21.1%
Operating Margin-2.8%
Revenue Growth87.4%
Free Cash Flow$-24M

Strata Critical Medical, Inc. operates in the Medical Care Facilities industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Strata Critical Medical, Inc.’s (SRTA) StockRank?
MoatMap’s StockRank for Strata Critical Medical, Inc. (SRTA) is 45/100, with a Hold signal. It is a composite of Quality (44), Value (36), and Momentum (59) factor ranks across MoatMap’s 20,000+ stock universe.
Does Strata Critical Medical, Inc. have an economic moat?
Strata Critical Medical, Inc. (SRTA) has a Quality factor score of 44/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Strata Critical Medical, Inc. a buy, hold, or sell?
MoatMap’s current signal for Strata Critical Medical, Inc. (SRTA) is Hold, based on a StockRank of 45/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Strata Critical Medical, Inc. in?
Strata Critical Medical, Inc. (SRTA) operates in the Healthcare sector, specifically the Medical Care Facilities industry (United States).
Browse all ranked stocksSRTA deep dive reportAI ChampionsHow we score stocksSense-check another stock